Cephalotaxine

CAS No. 24316-19-6

Cephalotaxine( (-)-Cephalotaxine, Cephalotaxine )

Catalog No. M17450 CAS No. 24316-19-6

Cephalotaxine is an antiviral and an antitumor agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
5MG 49 In Stock
10MG 69 In Stock
25MG 123 In Stock
50MG 176 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cephalotaxine
  • Note
    Research use only, not for human use.
  • Brief Description
    Cephalotaxine is an antiviral and an antitumor agent.
  • Description
    Cephalotaxine is an antiviral and antitumor agent.
  • In Vitro
    Cephalotaxine inhibits Zika infection by impeding viral replication and stability.
  • In Vivo
    ——
  • Synonyms
    (-)-Cephalotaxine, Cephalotaxine
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    Antiviral
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    24316-19-6
  • Formula Weight
    315.37
  • Molecular Formula
    C18H21NO4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL; 317.10 mM
  • SMILES
    O[C@H]1[C@@H]2[C@@]3(N(CCc4c2cc2OCOc2c4)CCC3)C=C1OC
  • Chemical Name
    (11bS,12S,14aR)-13-methoxy-2,3,5,6,11b,12-hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. M A Sells, et al. J Virol. 1988 Aug; 62(8): 2836–2844.
molnova catalog
related products
  • Panitumumab

    Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR).

  • JND3229

    JND3229 is a reversible EGFRC797S inhibitor with IC50 values of 5.8, 6.8 and 30.5 nM for EGFRL858R/T790M/C797S, EGFRWT and EGFRL858R/T790M, respectively.

  • Lumretuzumab

    Lumretuzumab (RG-7116) is a humanized anti-HER3 monoclonal antibody with antitumor activity for the study of advanced HER3-positive solid tumors and breast cancer.